Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-088218
Filing Date
2023-03-31
Accepted
2023-03-31 16:43:53
Documents
12
Period of Report
2023-03-29

Document Format Files

Seq Description Document Type Size
1 20-F d473873d20f.htm 20-F 207142
2 EX-1.1 d473873dex11.htm EX-1.1 319251
3 EX-2.3 d473873dex23.htm EX-2.3 22056
4 EX-4.5 d473873dex45.htm EX-4.5 110681
5 EX-4.8 d473873dex48.htm EX-4.8 124005
6 EX-8.1 d473873dex81.htm EX-8.1 2751
7 EX-15.1 d473873dex151.htm EX-15.1 338898
8 EX-15.2 d473873dex152.htm EX-15.2 1599
9 EX-15.3 d473873dex153.htm EX-15.3 2073
10 GRAPHIC g47387301prt3.jpg GRAPHIC 30251
11 GRAPHIC g473873dsp12.jpg GRAPHIC 24254
12 GRAPHIC g473873sp96a.jpg GRAPHIC 6770
  Complete submission text file 0001193125-23-088218.txt   1214224
Mailing Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404 1-650-209-4055
Apollomics Inc. (Filer) CIK: 0001944885 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41670 | Film No.: 23788635
SIC: 2834 Pharmaceutical Preparations